IQVIA accelerates obesity trials with integrated expertise, patient recruitment solutions, and advanced technology. A harmonized approach leverages exclusive datasets, patient journey mapping, and regulatory guidance to refine endpoints and boost enrollment. Rapid execution is achieved through efficient site activation, real-time recruitment optimization, patient navigators, and centralized data cleaning. Innovative tools like eCOA devices and connected systems ensure robust oversight. Cross-therapeutic expertise spans cardiovascular, endocrine, oncology, CNS, gastroenterology, respiratory, reproductive health, and rheumatology. With proven support for 100% of GLP-1 drugs in the past five years, IQVIA ensures faster, patient-centered trial delivery.

Join for free to read